A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan Inhalation Powder
NCT02905227
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
60
Enrollment
INDUSTRY
Sponsor class
Conditions
Migraine
Interventions
DRUG:
CVT-427 (zolmitriptan inhalation powder)
Sponsor
Acorda Therapeutics